Clinical Trials Directory

Trials / Completed

CompletedNCT03955120

Validation of the Dayzz Digital Sleep Training App in Insomnia and Sleep Apnea

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
125 (actual)
Sponsor
Dayzz Live Well Ltd. · Industry
Sex
All
Age
21 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The prevalence of sleep disorders has achieved epidemic proportions in Western countries. Despite this, assessment and treatment of sleep disorders remains infrequent, unattainable, and often costly. Dayzz is aware of the need for easily accessible, user-friendly, and affordable treatment strategies for known sleep conditions. This research proposes a randomized controlled outcome study aimed to validate a, digitized, cost-effective mobile app which assesses and manages insomnia and CPAP adherence in persons with sleep apnea. The app's sleep training protocols recommend life-style and behavioral changes and tracks these changes with the aim of improving sleep and well-being. In this study, the dayzz app digital treatment protocol will be compared to the standard treatment for these sleep conditions by a sleep professional.

Conditions

Interventions

TypeNameDescription
BEHAVIORALDayzz mobile sleep training1. The dayzz digital sleep program provides each user with relevant educational materials (depending on their sleep condition), sleep tracking, and sleep or health-related tasks or challenges pertaining to their sleep or sleep difficulties. 2. Each app user is matched with a "sleep trainer" who will communicate with them via a "chat" option within the dayzz app and who will support the participants with any sleep training issues or technical aspects of all app for the duration of the treatment program. 3. Participants receive a wrist-worn device for monitoring sleep and activity patterns, a Fitbit fitness tracker (www.fitbit.com), to be worn for the duration of the study.
OTHERTreatment as usualStandard medical care for specific sleep condition

Timeline

Start date
2019-01-29
Primary completion
2020-12-30
Completion
2020-12-30
First posted
2019-05-17
Last updated
2021-08-19

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT03955120. Inclusion in this directory is not an endorsement.